We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+22.62%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.77B
AUM Growth
+$282M
Cap. Flow
+$179M
Cap. Flow %
10.07%
Top 10 Hldgs %
30.07%
Holding
2,442
New
714
Increased
405
Reduced
476
Closed
723

Top Buys

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$43.9M
2
FDC
First Data Corporation
FDC
+$23.8M
3
ULTI
Ultimate Software Group Inc
ULTI
+$17.6M
4
CNC icon
Centene
CNC
+$16.8M
5
LXFT
Luxoft Holding, Inc.
LXFT
+$14.3M

Top Sells

Rank Stock Value
1
TFCF
Twenty-First Century Fox, Inc. Class B
TFCF
+$47.3M
2
SHPG
Shire pic
SHPG
+$43.4M
3
P
Pandora Media Inc
P
+$25.4M
4
IMPV
Imperva, Inc.
IMPV
+$19.5M
5
ATHN
Athenahealth, Inc.
ATHN
+$17.1M

Sector Composition

Rank Sector Weight
1 Technology 7.8%
2 Healthcare 6.74%
3 Communication Services 5.4%
4 Consumer Discretionary 5.34%
5 Real Estate 3.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DNKN
1301
DELISTED
Dunkin' Brands Group, Inc.
DNKN
$21K ﹤0.01%
+286
New +$20K
A icon
1302
Agilent Technologies
A
$41.2B
$20K ﹤0.01%
252
-2,270
-90% -$172K
AMD icon
1303
CALL
Advanced Micro Devices
AMD
$789B
$20K ﹤0.01%
+800
New +$18.2K
CCL icon
1304
PUT
Carnival Corporation Ltd
CCL
$39.7B
$20K ﹤0.01%
+400
New +$22.2K
EEFT icon
1305
Euronet Worldwide
EEFT
$2.7B
$20K ﹤0.01%
140
+86
+159% +$10.7K
KALV
1306
DELISTED
KalVista Pharmaceuticals
KALV
$20K ﹤0.01%
697
+100
+17% +$2.17K
KOS icon
1307
Kosmos Energy
KOS
$1.48B
$20K ﹤0.01%
+3,218
New +$17.9K
LAB icon
1308
Standard BioTools
LAB
$314M
$20K ﹤0.01%
1,512
-1,312
-46% -$13.8K
LZB icon
1309
PUT
La-Z-Boy
LZB
$1.69B
$20K ﹤0.01%
+600
New +$18.9K
MGRC icon
1310
McGrath RentCorp
MGRC
$2.92B
$20K ﹤0.01%
356
– –
QDEL icon
1311
QuidelOrtho
QDEL
$838M
$20K ﹤0.01%
304
-7,518
-96% -$455K
CORT icon
1312
Corcept Therapeutics
CORT
$12B
$19K ﹤0.01%
1,600
-75,906
-98% -$943K
AXIA
1313
DELISTED
AXIA Energia
AXIA
$19K ﹤0.01%
+2,509
New +$18.3K
EW icon
1314
PUT
Edwards Lifesciences
EW
$51.7B
$19K ﹤0.01%
+300
New +$17.1K
FMB icon
1315
First Trust Managed Municipal ETF
FMB
$2.06B
$19K ﹤0.01%
347
-8,123
-96% -$431K
IEX icon
1316
IDEX
IEX
$17.3B
$19K ﹤0.01%
123
+73
+146% +$10.3K
OIH icon
1317
CALL
VanEck Oil Services ETF
OIH
$1.84B
$19K ﹤0.01%
+55
New +$18.6K
WIRE
1318
DELISTED
Encore Wire Corp
WIRE
$19K ﹤0.01%
331
– –
ICPT
1319
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$19K ﹤0.01%
174
+101
+138% +$11K
ADTN icon
1320
Adtran
ADTN
$616M
$18K ﹤0.01%
+1,300
New +$18K
EBF icon
1321
Ennis
EBF
$564M
$18K ﹤0.01%
851
-176
-17% -$3.62K
LBTYK icon
1322
Liberty Global Class C
LBTYK
$3.49B
$18K ﹤0.01%
+741
New +$17.6K
QTWO icon
1323
Q2 Holdings
QTWO
$3.92B
$18K ﹤0.01%
+263
New +$16.4K
SPR
1324
PUT
DELISTED
Spirit AeroSystems
SPR
$18K ﹤0.01%
+200
New +$17.7K
TGNA
1325
DELISTED
TEGNA Inc
TGNA
$18K ﹤0.01%
1,260
-635
-34% -$8.06K
51 52
53
54 55

Similar funds

PFBT
Parkside Financial Bank & Trust Saint Louis, Missouri $1.31B AUM 19.14% 1-Year Est. Return
CCP
Clarkston Capital Partners Rochester, Michigan $1.31B AUM 3.79% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.3B AUM 21.43% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Prelude Capital Management's Q1 2019 Portfolio in Review

As of Q1 2019, Prelude Capital Management held 2,442 positions worth $1.77B, up 19% from $1.49B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Prelude Capital Management deployed $179M of net new capital in Q1 2019, opening 714 new positions and adding to 405 existing holdings. Its largest new stake was Ultimate Software Group Inc: 57,473 shares worth $19M.

By sector, the portfolio is most concentrated in Technology at 7.8% of assets, down from 12% a quarter earlier, followed by Healthcare and Communication Services.

On the sell side, the largest reduction was Integrated Device Technology I, an estimated $12.7M trimmed.

  • Prelude Capital Management's largest Q1 2019 buy was Ultimate Software Group Inc: 57,473 shares worth $19M.
  • Prelude Capital Management added most to Celgene Corp in Q1 2019, an estimated $43.9M increase.
  • Prelude Capital Management's biggest Q1 2019 reduction was Integrated Device Technology I, cutting an estimated $12.7M.
  • Prelude Capital Management fully exited Twenty-First Century Fox, Inc. Class B in Q1 2019, selling an estimated $47.3M.
  • Prelude Capital Management's ten largest holdings make up 30% of its $1.77B portfolio in Q1 2019.
  • Prelude Capital Management opened 714 new positions and closed 723 in Q1 2019.
  • Prelude Capital Management's portfolio value rose 19% quarter-over-quarter to $1.77B.

Based on Prelude Capital Management's 13F filing for Q1 2019, filed 15 May 2019.